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ALTHOUGH tacrolimus-based immunosuppression has made clinical intestinal transplantation feasible. 
the risk of the requisite long-term high-dose treatment has 
inhibited the widespread use of these procedures. 1 Such a 
risk could be partially eliminated with safe adjustment of 
the current immunosuppressive management protocol ac-
cording to the type of intestinal allograft. 
MATERIALS AND METHODS 
Between May 2, 1990 and May 4, 1999. 124 consecutive patients 
received a total of 130 intestinal allografts: 51 isolated intestine and 
79 composite visceral grafts (62 liver :!: intestine and 17 multivis-
ceral). Of these. 73 (59%) were children and 51 (41%) were adults. 
All grafts were cadaveric and ABO identical. No attempts were 
made to alter the graft immunologic tissue with irradiation. anti-
lymphocyte preparations. or other modalities. HLA matching was 
random and crossmatch testing was positive in 18% of the grafts. 
The mean cold ischemia time was 8.7 :!: 7 hours. Baseline 
immunosuppression was done with tacrolimus and steroids. and 
daclizumab was used as induction therapy in the last 17 grafts. A 
single dose of unmodified donor bone marrow cells (3 to 5 x lOS 
cells/kg body weight) was infused intravenously during the first 24 
hours after transplantation in 26 recipients. Azathioprine or myco-
phenolate mofetil was given from the outset in selected cases. 
Steroid-resistant rejection was treated with OKT3. Details of the 
donor and recipient operations were previously published 1-4 and 
the same immunosuppressive protocol was used for both the 
isolated intestinal and composite visceral recipients as described 
elsewhere.1.4 Chi-square and Fisher Exact tests were used for 
statistical analysis. 
RESULTS 
With a median follow-up of 41 months (range 0 to 109), 71 
grafts were lost with an overall incidence of 55%. Of these. 
26 were isolated intestine and 45 were composite visceral 
grafts. Forty-four (62%) were lost during the first 12 
postoperative months (early) at a median time of 57 days. 
The remaining 27 (38%) grafts were lost 13 to 85 months 
after transplantation (late) with a median time of 26 
months. The overall leading causes of graft loss were 
opportunistic infection (44%) and refractory rejection 
(30%). 
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Refractory rejection occurred at a significantly (P = 
.0007) higher rate when comparing the isolated intestine 
(54%) with the composite visceral (16%) grafts. Such a 
difference was maintained at a statistically significant level 
during both the early (57% vs 20%) and late (50% vs 7%) 
postoperative follow-up period with P values of .014 and 
.023, respectively. Chronic rejection was histologically doc-
umented in the enterectomy specimen of nine (35%) iso-
lated intestinal grafts with a higher frequency during the 
late postoperative period (50%) compared to the first year 
after transplantation (21 %). There was only one example of 
chronic rejection (late) of both liver and intestine in a 
composite visceral allograft that was given to an adult 
recipient across a strong positive crossmatch. 
Lethal infections. including posttransplant lymphoprolif-
erative disorder (PTLD) and cytomegalovirus (CMV), de-
veloped at a significantly (P = .03) higher rate among the 
composite visceral recipients (53%) compared to patients 
who received isolated intestine (27%). Such a difference 
was more significant (P = .007) during the late postopera-
tive period with a rate of 80% and 25%, respectively. 
DISCUSSION 
With a similar immunosuppressive management protocol, 
the isolated intestinal allografts were at a significantly 
higher risk of intractable rejection compared to the com-
posite visceral allografts that contained liver. Equally im-
portant was the occurrence of uncontrollable rejection at a 
relatively high frequency beyond the first postoperative year 
after isolated intestinal transplantation. The documented 
high incidence of lethal infections among the composite 
allograft recipients reflects the complexity of the operative 
technique and perioperative management of these high-risk 
patients. However, the development of lethal infections at a 
relatively high rate long after transplantation might reflect 
the long-term complications of the unified immunosuppres-
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sive protocol that was adopted for these patients. particu-
larly during the early phase of the study period. 
In conclusion. isolated intestinal allografts are at a sig-
nificantly higher risk for intractable acute and chronic 
rejection compared to the composite visceral grafts that 
contained liver. Until a better immunomodulation strategy 
is available. the current immunosuppressive regimen should 
be adjusted for each individual recipient and maintenance 
therapy should be kept at a relatively high level for the 
isolated intestinal recipients. 
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